

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $168.79
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| May 28, 26 |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| May 15, 19 | Piper Vinita Lee | director | D | 0 | — |
| RBC Capital |
| maintain |
| Sector Perform |
| Sector Perform |
| Oct 3, 25 | RBC Capital | downgrade | Outperform | Sector Perform |
| Aug 27, 25 | RBC Capital | maintain | Outperform | Outperform |
| Feb 26, 25 | RBC Capital | maintain | Outperform | Outperform |
| Jan 9, 25 | RBC Capital | upgrade | Sector Perform | Outperform |
| Dec 6, 24 | RBC Capital | maintain | Sector Perform | Sector Perform |
| Aug 28, 24 | Barclays | maintain | Overweight | Overweight |
| Aug 28, 24 | B of A Securities | downgrade | Buy | Neutral |
| Aug 28, 24 | Scotiabank | downgrade | Sector Outperform | Sector Perform |
| May 15, 19 |
| Piper Vinita Lee |
| director |
| 0 |
| — |
| May 15, 19 | Piper Vinita Lee | director: | 0 | — |
| May 15, 19 | Piper Vinita Lee | director | D | 0 | — |
Stock news · updated daily
Shares of Bank of Montreal (TSE: BMO - Get Free Report) (NYSE: BMO) have received an average recommendation of "Hold" from the thirteen ratings firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and seven have issued a buy rating
Shares of Bank Of Montreal (NYSE: BMO - Get Free Report) (TSE: BMO) have earned an average recommendation of "Hold" from the thirteen ratings firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and six have assigned a buy
Executive with three decades of life sciences financing and M&A experience joins the board as Lobe advances L-130 in anxiety and cluster headache and S-100 in sickle cell disease VANCOUVER, BC / ACCESS Newswire / October 14, 2026 / Lobe Sciences Ltd. ("Lobe Sciences" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), a clinical-stage biopharmaceutical company focused on advancing therapies for diseases with significant unmet medical needs, today announced the appointment of Annette Grimaldi to its Board of Directors.
Earl Davis, BMO Global Asset Management fixed income and money markets head, says it's inevitable that 30-year treasury bond yields will cross 6%. He says it could happen this month and explains the call on "Bloomberg Surveillance.
BMO and Mastercard have launched a new embedded commercial payments capability that can be integrated into participating enterprise software platforms in Canada and the United States, BMO said in a Thursday (Oct. 1) press release.
Independent Bank (NASDAQ: INDB - Get Free Report) and Bank Of Montreal (NYSE: BMO - Get Free Report) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends and earnings. Profitability This table compares Independent Bank and
MidWestOne Financial Group (NASDAQ: MOFG - Get Free Report) and Bank Of Montreal (NYSE: BMO - Get Free Report) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings. Earnings and Valuation This table compares
Shares of Bank Of Montreal (NYSE: BMO - Get Free Report) (TSE: BMO) have earned a consensus rating of "Hold" from the twelve research firms that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and five have assigned a buy recommendation
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 25, 2026 | 2.71 | 2.84 | Beat 4.8% | $7.10B |
| May 27, 2026 | 2.54 | 2.68 | Beat 5.5% | $7.04B |
| Feb 25, 2026 | 2.35 | 2.51 | Beat 6.8% | $7.21B |
| Dec 4, 2025 | 2.16 | 2.36 | Beat 9.3% | $6.66B |
| Aug 26, 2025 | 2.12 | 2.33 | Beat 9.9% | $8.94B |
| May 28, 2025 | 1.84 | 1.84 | Beat 0.0% | $8.68B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 424B2 | Oct 23, 2026 | 2026-10-23 14:10:43 | View |
| 424B2 | Oct 23, 2026 | 2026-10-23 14:10:37 | View |
| 424B2 | Oct 23, 2026 | 2026-10-23 13:01:23 | View |
| FWP | Oct 23, 2026 | 2026-10-23 12:01:41 | View |
| 424B2 | Oct 23, 2026 | 2026-10-23 11:48:04 | View |
| 424B2 | Oct 23, 2026 | 2026-10-23 11:37:08 | View |
| 424B2 | Oct 23, 2026 | 2026-10-23 11:17:21 | View |
| 424B2 | Oct 23, 2026 | 2026-10-23 11:12:40 | View |
| FWP | Oct 22, 2026 | 2026-10-22 16:58:03 | View |
| FWP | Oct 22, 2026 | 2026-10-22 16:25:39 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | BMO | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 19.2x | 12.9x · sector 20.4x | In line |
| Forward P/E (FY26E) | 11.4x | EPS est. 14.85 | Discount |
| Price / Book | 1.9x | 1.2x | Elevated |
| Price / Sales | 2.1x | 1.8x | Elevated |
| EV / EBITDA | 17.7x | 30.2x | Discount |
| Return on equity | 10.6% | — | Healthy |
| Gross margin | 45.6% | 54.7% | Below hist. |
| Debt / Equity | 1.93 | 4.68 | Levered |
| Piotroski / Altman Z | 8/9 | Z 0.14 | Distress |
Discounted cash flow model
1255 daily bars · split adjusted
FY2025 · 10-K disclosure
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 51.07 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 92.92 | Oscillator | Sell |
| Williams %R (14) | -17.36 | Oscillator | Sell |
| MACD (12, 26, 9) | -0.73 (Hist 0.95) | Oscillator | Buy |
| Average Directional Index (14) | 25.58 (+DI 22.8 / -DI 21.4) | Trend | Strong Buy |
| EMA 20 | 167.70 | MA | Buy |
| SMA 20 | 166.23 | MA | Buy |
| EMA 50 | 169.87 | MA | Sell |
| SMA 50 | 171.16 | MA | Sell |
| SMA 200 | 159.04 | MA | Strong Buy |